What is Viome Life Sciences worth?
$415.4Mlast known valuation
Viome Life Sciences last raised $25.4M in its Early Stage VC (Aug 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Viome Life Sciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2024 | Early Stage VC | $25.4M | ▮ | ▮ |
| Sep 2022 | Later Stage VC | $67.0M | ▮ | ▮ |
How Viome Life Sciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Viome Life Sciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Viome Life Sciences worth?
- Viome Life Sciences's last known valuation is $415.4M.
- How much has Viome Life Sciences raised?
- Viome Life Sciences has raised $235.4M in total funding across 2 recorded rounds.
- When did Viome Life Sciences last raise?
- Viome Life Sciences last raised in Aug 2024 (Early Stage VC), raising $25.4M.